Rimegepant
Back to searchMolecule Structure
Scientific Name
Rimegepant
Description of the Drug
Rimegepant is an oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12457
http://www.drugbank.ca/drugs/DB12457
Brand Name(s)
Not Available
Company Owner(s)
Biohaven Pharmaceutical Ireland Designated Activity Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Calcitonin gene-related peptide type 1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL3798 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1670580 | |
| Human Metabolome Database | HMDB0304859 | |
| DrugBank | DB12457 | |
| PubChem: Thomson Pharma | 118044283 | |
| PubChem | 51049968 | |
| LINCS | LSM-45712 | |
| Nikkaji | J3.353.241E | |
| BindingDB | 50400098 | |
| EPA CompTox Dashboard | DTXSID70156003 | |
| DrugCentral | 5381 | |
| ChemicalBook | CB42645135 | |
| Guide to Pharmacology | 10704 | |
| rxnorm | RIMEGEPANT | RIMEGEPANT SULFATE |
| ZINC | ZINC000068267814 |
